References
- Ahmed, O. M., Mao, J. A., Holt, S. R., Hawk, K., D’Onofrio, G., Martel, S., & Melnick, E. R. (2019). A scalable, automated warm handoff from the emergency department to community sites offering continued medication for opioid use disorder: Lessons learned from the EMBED trial stakeholders. Journal of Substance Abuse Treatment, 102, 47–52. https://doi.org/https://doi.org/10.1016/j.jsat.2019.05.006
- Bandura, A. (1971). Social learning theory. General Learning Press.
- Bassuk, E. L., Hanson, J., Greene, R. N., Richard, M., & Laudet, A. (2016). Peer-delivered recovery support services for addictions in the United States: A systematic review. Journal of Substance Abuse Treatment, 63, 1–9. https://doi.org/https://doi.org/10.1016/j.jsat.2016.01.003
- Center for Disease Control. National Center for Health Statistics. (2021). Provisional drug overdose death counts. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm
- Cunningham, C. O., Sohler, N. L., McCoy, K., & Kunins, H. V. (2006). Attending physicians’ and residents’ attitudes and beliefs about prescribing buprenorphine at an urban teaching hospital. Family Medicine, 38(5), 336–340.
- D’Onofrio, G., O’Connor, P. G., Pantalon, M. V., Chawarski, M. C., Busch, S. H., Owens, P. H., Bernstein, S. L., & Fiellin, D. A. (2015). Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: A randomized clinical trial. JAMA, 313(16), 1636–1644. https://doi.org/https://doi.org/10.1001/jama.2015.3474
- Dunkley, C. A., Carpenter, J. E., Murray, B. P., Sizemore, E., Wheatley, M., Morgan, B. W., Moran, T. P., & Steck, A. (2019). Retrospective review of a novel approach to buprenorphine induction in the emergency department. The Journal of Emergency Medicine, 57(2), 181–186. https://doi.org/https://doi.org/10.1016/j.jemermed.2019.03.029
- Edwards, F. J., Wicelinski, R., Gallagher, N., McKinzie, A., White, R., & Domingos, A. (2020). Treating opioid withdrawal with buprenorphine in a community hospital emergency department: An outreach program. Annals of Emergency Medicine, 75(1), 49–56. https://doi.org/https://doi.org/10.1016/j.annemergmed.2019.08.420
- Gagne, C., Olivet, J., & Davis, L. (2012). Equipping behavioral health systems & authorities to promote peer specialist/peer recovery coaching services: Expert panel meeting report. March 21–22, Center for Mental Health Services and the Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration.
- Hawk, K. F., D’Onofrio, G., Chawarski, M. C., O’Connor, P. G., Cowan, E., Lyons, M. S., Richardson, L., Rothman, R. E., Whiteside, L. K., Owens, P. H., Martel, S. H., Coupet, E., Pantalon, M., Curry, L., Fiellin, D. A., & Edelman, E. J. (2020). Barriers and facilitators to clinical readiness to provide emergency dept-initiated buprenorphine. JAMA Network Open, 3(5), e204561. https://doi.org/https://doi.org/10.1001/jamanetworkopen.2020.4561
- Herring, A. A., Perrone, J., & Nelson, L. S. (2019). Managing opioid withdrawal in the emergency department with buprenorphine. Annals of Emergency Medicine, 73(5), 481–487. https://doi.org/https://doi.org/10.1016/j.annemergmed.2018.11.032
- Hu, T., Snider-Adler, M., Nijmeh, L., & Pyle, A. (2019). Buprenorphine/naloxone induction in a Canadian emergency department with rapid access to community-based addictions providers. CJEM, 21(4), 492–498. https://doi.org/https://doi.org/10.1017/cem.2019.24
- Hutchinson, E., Catlin, M., Andrilla, C. H. A., Baldwin, L.-M., & Rosenblatt, R. A. (2014). Barriers to primary care physicians prescribing buprenorphine. Annals of Family Medicine, 12(2), 128–133. https://doi.org/https://doi.org/10.1370/afm.1595
- Kaucher, K. A., Caruso, E. H., Sungar, G., Gawenus, L., Hurlbut, K., Sanchez, D. C., & Broderick, K. (2020). Evaluation of an emergency department buprenorphine induction and medication-assisted treatment referral program. The American Journal of Emergency Medicine, 38(2), 300–304. https://doi.org/https://doi.org/10.1016/j.ajem.2019.158373
- Kelly, T., Hoppe, J. A., Zuckerman, M., Khoshnoud, A., Sholl, B., & Heard, K. (2020). A novel social work approach to emergency department buprenorphine induction and warm hand-off to community providers. The American Journal of Emergency Medicine, 38(6), 1286–1290. https://doi.org/https://doi.org/10.1016/j.ajem.2019.12.038
- Kissin, W., McLeod, C., Sonnefeld, J., & Stanton, A. (2006). Experiences of a national sample of qualified addiction specialists who have and have not prescribed buprenorphine for opioid dependence. Journal of Addictive Diseases, 25(4), 91–10. https://doi.org/https://doi.org/10.1300/J069v25n04_09
- LaBelle, C. T., Han, S. C., Bergeron, A., & Samet, J. H. (2016). Office-based opioid treatment with buprenorphine (OBOT-B): Statewide implementation of the Massachusetts collaborative care model in community health centers. Journal of Substance Abuse Treatment, 60, 6–13. https://doi.org/https://doi.org/10.1016/j.jsat.2015.06.010
- Larochelle, M. R., Bernson, D., Land, T., Stopka, T. J., Wang, N., Xuan, Z., Bagley, S. M., Liebschutz, J. M., & Walley, A. Y. (2018). Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: A cohort study. Annals of Internal Medicine, 169(3), 137–145. https://doi.org/https://doi.org/10.7326/M17-3107
- Liebschutz, J. M., Crooks, D., Herman, D., Anderson, B., Tsui, J., Meshesha, L. Z., Dossabhoy, S., & Stein, M. (2014). Buprenorphine treatment for hospitalized, opioid-dependent patients: A randomized clinical trial. JAMA Internal Medicine, 174(8), 1369–1376. https://doi.org/https://doi.org/10.1001/jamainternmed.2014.2556
- Lipari, R. N., Park-Lee, E., & Van Horn, S. (2016). America’s need for and receipt of substance use treatment in 2015. The CBHSQ Report: September 29, Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration.
- Livingston, J. D., Milne, T., Fang, M. L., & Amari, E. (2012). The effectiveness of interventions for reducing stigma related to substance use disorders: A systematic review. Addiction (Abingdon, England), 107(1), 39–50. https://doi.org/https://doi.org/10.1111/j.1360-0443.2011.03601.x
- Lukas, C. V., Holmes, S. K., Cohen, A. B., Restuccia, J., Cramer, I. E., Shwartz, M., & Charns, M. P. (2007). Transformational change in health care systems: An organizational model. Health Care Management Review, 32(4), 309–320. https://doi.org/https://doi.org/10.1097/01.HMR.0000296785.29718.5d
- Martin, S. A., Chiodo, L. M., Bosse, J. D., & Wilson, A. (2018). The next stage of buprenorphine care for opioid use disorder. Annals of Internal Medicine, 169(9), 628–635. https://doi.org/https://doi.org/10.7326/M18-1652
- Rapoport, A. B., & Rowley, C. F. (2017). Stretching the scope - becoming frontline addiction-medicine providers. The New England Journal of Medicine, 377(8), 705–707. https://doi.org/https://doi.org/10.1056/NEJMp1706492
- Reif, S., Braude, L., Lyman, D. R., Dougherty, R. H., Daniels, A. S., Ghose, S. S., Salim, O., & Delphin-Rittmon, M. E. (2014). Peer recovery support for individuals with substance use disorders: Assessing the evidence. Psychiatric Services (Washington, D.C.), 65(7), 853–861. https://doi.org/https://doi.org/10.1176/appi.ps.201400047
- Reinertsen, J. L., Bisognano, M., & Pugh, M. D. (2008). Seven leadership leverage points for organizational-level. improvement in health care (2nd ed.). Institution for Healthcare Improvement. www.ihi.org
- Ross, D., Lo, F., McKim, R., & Allan, G. M. (2008). A primary care/multidisciplinary harm reduction clinic including opiate bridging. Substance Use & Misuse, 43(11), 1628–1639. https://doi.org/https://doi.org/10.1080/10826080802241193
- Saloner, B., Stoller, K. B., & Alexander, G. C. (2018). Moving addiction care to the mainstream - Improving the quality of buprenorphine treatment. The New England Journal of Medicine, 379(1), 4–6. https://doi.org/https://doi.org/10.1056/NEJMp1804059
- Snow, R. L., Simon, R. E., Jack, H. E., Oller, D., Kehoe, L., & Wakeman, S. E. (2019). Patient experiences with a transitional, low-threshold clinic for the treatment of substance use disorder: A qualitative study of a bridge clinic. Journal of Substance Abuse Treatment, 107, 1–7. https://doi.org/https://doi.org/10.1016/j.jsat.2019.09.003
- Sordo, L., Barrio, G., & Bravo, M. J. (2017). Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies. British Medical Journal, 57, j1550.
- Srivastava, A., Kahan, M., Njoroge, I., & Sommer, L. Z. (2019). Buprenorphine in the emergency department: Randomized clinical controlled trial of clonidine versus buprenorphine for the treatment of opioid withdrawal. Canadian Family Physician Medecin de Famille Canadien, 65(5), e214–e220.
- Stoller, K. B., Bigelow, G. E., Walsh, S. L., & Strain, E. C. (2001). Effects of buprenorphine/naloxone in opioid-dependent humans. Psychopharmacology, 154(3), 230–242. https://doi.org/https://doi.org/10.1007/s002130000637
- Strayer, R. J., Herring, A. A., & Nelson, L. S. (2019). Balancing benefits and harms on the frontier of buprenorphine initiation. Annals of Emergency Medicine, 74(3), 433–435. https://doi.org/https://doi.org/10.1016/j.annemergmed.2019.04.024
- Substance Abuse and Mental Health Services Administration (SAMHSA). (2016). Sublingual and transmucosal buprenorphine for opioid use disorder: review and update. Advisory 15.
- Suzuki Jm Devido, J., & Kalra, I. (2014). Initiating buprenorphine treatment for hospitalized patients with opioid dependence: A case series. The American Journal on Addictions, 24, 10–14. https://doi.org/https://doi.org/10.1002/AJAD.12161.x
- Tong, A., Sainsbury, P., & Craig, J. (2007). Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. International Journal for Quality in Health Care, 19(6), 349–357. https://doi.org/https://doi.org/10.1093/intqhc/mzm042
- Tracy, K., Burton, M., Nich, C., & Rounsaville, B. (2011). Utilizing peer mentorship to engage high recidivism substance-abusing patients in treatment. The American Journal of Drug and Alcohol Abuse, 37(6), 525–531. https://doi.org/https://doi.org/10.3109/00952990.2011.600385
- Volkow, N. D., Frieden, T. R., Hyde, P. S., & Cha, S. S. (2014). Medication-assisted therapies-tackling the opioid-overdose epidemic. The New England Journal of Medicine, 370(22), 2063–2066. https://doi.org/https://doi.org/10.1056/NEJMp1402780
- Walley, A. Y., Alperen, J. K., Cheng, D. M., Botticelli, M., Castro-Donlan, C., Samet, J. H., & Alford, D. P. (2008). Office-based management of opioid dependence with buprenorphine: Clinical practices and barriers. Journal of General Internal Medicine, 23(9), 1393–1398. https://doi.org/https://doi.org/10.1007/s11606-008-0686-x